ACE Inhibitor–Associated Cough in Children Common but Usually Well Tolerated compared to adults: Study

Written By :  Dr. Shravani Dali
Published On 2026-02-19 15:30 GMT   |   Update On 2026-02-19 15:30 GMT

Researchers have found in a new retrospective study that cough related to ACE inhibitor use in children may be more prevalent than previously recognized, but it is typically mild, well tolerated, and seldom requires changes in treatment or management.

ntroduction: ACE inhibitors are commonly prescribed in children. Anecdotally, captopril- induced cough is not thought to occur in children as frequently as in adults.


They performed a retrospective cohort study in 100 paediatric cardiology patients taking regular ACE inhibitors (ACE-I). Telephone interviews and questionnaires were used to ask patients and their families about their experience of ACE-I–related cough symptoms. Results: Of the 100 patients, 15% reported symptoms of captopril-related cough. Only 1% required a change in medication due to their cough. Captopril-related cough appears to be less significant in children than in adult populations. The reason for this is unclear, but it may be related to differences in ACE expression between adult and paediatric lungs.

The results suggest that cough associated with ACE-I use may be more prevalent in children than previously thought; however, it is generally well tolerated and rarely necessitates a change in management. Overall, these findings have practical implications for clinical decision-making in paediatric cardiology. While cough is a recognised adverse effect of ACE inhibitors, the low rate of treatment discontinuation in this cohort suggests that captopril remains a generally acceptable and manageable therapy for most children. Awareness of this potential side effect may help clinicians counsel families more effectively, distinguish medication-related cough from intercurrent respiratory illness, and avoid unnecessary medication changes. Further prospective studies with objective cough assessment and longer follow-up may help clarify the true incidence, underlying mechanisms, and age-related differences in ACE inhibitor–associated cough in paediatric populations.

Reference:

Coffey, M., McCrossan, B., Moore, R., & Shields, M. (2026). Captopril-induced cough: Does it matter in children? A retrospective cohort study. In Press. https://doi.org/10.2174/0115733963356686251201052241


Keywords:

ACE inhibitor–associated cough, pediatric hypertension, children, adults, angiotensin-converting enzyme inhibitors, ACE inhibitors, adverse drug reaction, cough incidence, tolerability, pediatric pharmacology, randomized controlled trials, ACE inhibitor vs ARB, bradykinin accumulation, drug safety in children, Cough, captopril, captopril cough, cardiology, pharmacology, pediatrics.



Tags:    
Article Source : In Press

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News